Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

洛赛克MUPS - NMPA Drug Approval Details

Approvals/NMPA/Omeprazole Magnesium Enteric-Coated Tablets

Approved

化学药品

Omeprazole Magnesium Enteric-Coated Tablets

ASTRAZENECA PTY LTD🇨🇳 National Medical Products Administration

Approval Date: Feb 13, 2023
Approval ID: 6fbf43532be9d185
Company: ASTRAZENECA PTY LTD
Type: 化学药品

Approval Details

Approval Id: 6fbf43532be9d185
Approval Number: 国药准字HJ20181232
Generic Name: 奥美拉唑镁肠溶片
Generic Name En: Omeprazole Magnesium Enteric-Coated Tablets
Trade Name: 洛赛克MUPS
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 10mg（以C₁₇H₁₉N₃O₃S计）
Reg Date: 2023-02-13
Expired Date: 2027-10-24
Company Name: ASTRAZENECA PTY LTD
Production Company Name: ASTRAZENECA AB
Company Detail Path: /organization/astrazeneca-pty-ltd
Production Company Detail Path: /organization/astrazeneca-ab

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 13, 2023

Approval ID

6fbf43532be9d185

Type

化学药品

Back to NMPA Approvals